Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
RGNX
REGENXBIO Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$7.53
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$497.08M
Country
USA
RECENT INSIDER TRADES
2026-09-03
· Malzahn Craig
(Chief Technology Officer)
· OTHER
2026-09-03
· Chan Mitchell
(Chief Financial Officer)
· OTHER
2026-08-27
· Ciongoli Gregory Austin
(Director)
· BUY
2026-07-06
· PAKOLA STEVE
(Chief Medical Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
185
Shares held
55,731,427
Value
$664.81M
Percent of shares outstanding
84.42%
As of quarter end
2026-06-30
RECENT NEWS
REGENXBIO to host investor event on Sura-vec wet AMD program October 20
Regenxbio a new Outperform at Mizuho on potential of two pipeline drugs
Mizuho initiates Regenxbio stock coverage with outperform rating
REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
REGENXBIO presents at Morgan Stanley healthcare conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
REGENXBIO Inc. (RGNX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit